BACKGROUND: The diagnosis of cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis (PSC) is particularly difficult. The role of volatile organic compounds (VOCs) for diagnosis of CCA in patients with PSC is not known. OBJECTIVE: Our aim was to identify potential VOCs in the headspaces (gas above the sample) in bile that may predict CCA in patients with PSC. DESIGN: Prospective cross-sectional study. SETTING: Referral center. PATIENTS: A total of 32 patients undergoing ERCP for PSC and for CCA complicating PSC. INTERVENTIONS: ERCP, bile aspiration. MAIN OUTCOME MEASUREMENTS: Selected ion flow tube mass spectrometry was used to analyze the concentration of 22 prevalent VOCs in bile samples. Logistic regression analysis was performed to build a predictive model for diagnosis of CCA. RESULTS: Levels of several compounds (ethanol, acrylonitrile, acetonitrile, acetaldehyde, benzene, carbon disulfide, dimethyl sulfide, 2-propranolol) were significantly different in patients with CCA complicating PSC compared with those having PSC (P < .05). By using receiver operating characteristic curve analysis, we developed a model for the diagnosis of CCA adjusted for age and sex based on VOC levels of acrylonitrile, 3-methyl hexane, and benzene. The model (2.3239*log [acrylonitrile] + 0.9871*log [3-methyl hexane] + 0.8448*log [benzene]) < -0.12 identified the patients with CCA (area under the curve [AUC] = 0.89), with 90.5% sensitivity and 72.7% specificity (P = .02). LIMITATIONS: Sample size. CONCLUSION: The measurement of VOCs in biliary fluid may be useful to diagnose CCA in patients with PSC. A larger study with a longitudinal study design is required to confirm our pilot observations to diagnose CCA early in patients with PSC. ( CLINICAL TRIAL REGISTRATION NUMBER: NCT01565460.).
BACKGROUND: The diagnosis of cholangiocarcinoma (CCA) in patients with primary sclerosing cholangitis (PSC) is particularly difficult. The role of volatile organic compounds (VOCs) for diagnosis of CCA in patients with PSC is not known. OBJECTIVE: Our aim was to identify potential VOCs in the headspaces (gas above the sample) in bile that may predict CCA in patients with PSC. DESIGN: Prospective cross-sectional study. SETTING: Referral center. PATIENTS: A total of 32 patients undergoing ERCP for PSC and for CCA complicating PSC. INTERVENTIONS: ERCP, bile aspiration. MAIN OUTCOME MEASUREMENTS: Selected ion flow tube mass spectrometry was used to analyze the concentration of 22 prevalent VOCs in bile samples. Logistic regression analysis was performed to build a predictive model for diagnosis of CCA. RESULTS: Levels of several compounds (ethanol, acrylonitrile, acetonitrile, acetaldehyde, benzene, carbon disulfide, dimethyl sulfide, 2-propranolol) were significantly different in patients with CCA complicating PSC compared with those having PSC (P < .05). By using receiver operating characteristic curve analysis, we developed a model for the diagnosis of CCA adjusted for age and sex based on VOC levels of acrylonitrile, 3-methyl hexane, and benzene. The model (2.3239*log [acrylonitrile] + 0.9871*log [3-methyl hexane] + 0.8448*log [benzene]) < -0.12 identified the patients with CCA (area under the curve [AUC] = 0.89), with 90.5% sensitivity and 72.7% specificity (P = .02). LIMITATIONS: Sample size. CONCLUSION: The measurement of VOCs in biliary fluid may be useful to diagnose CCA in patients with PSC. A larger study with a longitudinal study design is required to confirm our pilot observations to diagnose CCA early in patients with PSC. ( CLINICAL TRIAL REGISTRATION NUMBER: NCT01565460.).
Authors: D F Altomare; M Di Lena; F Porcelli; L Trizio; E Travaglio; M Tutino; S Dragonieri; V Memeo; G de Gennaro Journal: Br J Surg Date: 2013-01 Impact factor: 6.939
Authors: Jesica Dadamio; Sandra Van den Velde; Wim Laleman; Paul Van Hee; Wim Coucke; Frederik Nevens; Marc Quirynen Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2012-07-31 Impact factor: 3.205
Authors: Udayakumar Navaneethan; Mansour A Parsi; Norma G Gutierrez; Amit Bhatt; Preethi G K Venkatesh; Dennisdhilak Lourdusamy; David Grove; Jeffrey P Hammel; Sunguk Jang; Madhusudhan R Sanaka; Tyler Stevens; John J Vargo; Raed A Dweik Journal: Gastrointest Endosc Date: 2014-06-11 Impact factor: 9.427
Authors: Sandra Van den Velde; Frederik Nevens; Paul Van Hee; Daniel van Steenberghe; Marc Quirynen Journal: J Chromatogr B Analyt Technol Biomed Life Sci Date: 2008-09-17 Impact factor: 3.205
Authors: Jesus M Banales; Vincenzo Cardinale; Guido Carpino; Marco Marzioni; Jesper B Andersen; Pietro Invernizzi; Guro E Lind; Trine Folseraas; Stuart J Forbes; Laura Fouassier; Andreas Geier; Diego F Calvisi; Joachim C Mertens; Michael Trauner; Antonio Benedetti; Luca Maroni; Javier Vaquero; Rocio I R Macias; Chiara Raggi; Maria J Perugorria; Eugenio Gaudio; Kirsten M Boberg; Jose J G Marin; Domenico Alvaro Journal: Nat Rev Gastroenterol Hepatol Date: 2016-04-20 Impact factor: 46.802
Authors: Udayakumar Navaneethan; Dennisdhilak Lourdusamy; Norma G Gutierrez; Xiang Zhu; John J Vargo; Mansour A Parsi Journal: Endosc Int Open Date: 2017-08-07
Authors: Lorenzo Monasta; Chiara Pierobon; Andrea Princivalle; Stefano Martelossi; Annalisa Marcuzzi; Francesco Pasini; Luigi Perbellini Journal: PLoS One Date: 2017-08-31 Impact factor: 3.240